Specific IgG to gelatin in children with systemic immediate-and nonimmediate-type reactions to measles, mumps and rubella vaccines

Vaccine

Volumn 17, Issue 17, 1999, Pages 2176-2180

  Miyazawa, Hiroshi ^a   Saitoh, Saburo ^b   Kumagai, Takuji ^c   Yamanaka, Tatsuru ^c   Yasuda, Sachiko ^d   Tsunetsugu Yokota, Yasuko ^d   Inouye, Sakae ^d   Sakaguchi, Masahiro ^d  

^a KYORIN UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Pediat Allerg Infect Dis Soc S   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Anaphylaxis; Gelatin; IgE; IgG; Urticaria; Vaccines

Indexed keywords

GELATIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE;

AIRWAY OBSTRUCTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; INFANT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEASLES VACCINATION; PATHOGENESIS; PRIORITY JOURNAL; URTICARIA; VACCINATION;

ANIMALS; ANTIBODY SPECIFICITY; CATTLE; CHILD, PRESCHOOL; FEMALE; GELATIN; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; LYMPHOCYTE ACTIVATION; MALE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE; VIRAL VACCINES;

EID: 0033597326     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00368-5     Document Type: Article

References (17)

1. Zimmerman B, Zimmerman RS. Adverse reactions to vaccines. In: Middleton EJ, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, editors. Allergy: principles and practice. St. Louis: C.V. Mosby, 1993. p. 1705-25.
2. Businco L. Measles, mumps, rubella immunization in egg-allergic children: a long-lasting debate. Ann Allergy. 72:1994;1-3.
3. Kelso J.M., Jones R.T., Yunginger J.W. Anaphylaxis to measles, mumps and rubella vaccine mediated by IgE to gelatin. J Allergy Clin Immunol. 91:1993;867-872.
4. Sakaguchi M., Ogura H., Inouye S. IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines. J Allergy Clin Immunol. 96:1995;563-565.
5. Sakaguchi M., Yamanaka T., Ikeda K., Sano Y., Fujita H., Miura T., Inouye S. IgE-mediated systemic reactions to gelatin included in the varicella vaccine. J Allergy Clin Immunol. 99:1997;263-264.
6. Sakaguchi M., Nakayama T., Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions including anaphylaxis to vaccines. J Allergy Clin Immunol. 98:1996;1058-1061.
7. Sakaguchi M., Yoshida T., Asahi T., Aoki T., Miyatani Y., Inouye S. Development of IgE antibody to gelatin in children with anaphylactic reactions to vaccines. J Allergy Clin Immunol. 99:1997;720-721.
8. Yamanaka T., Wataya Y., Kumagai T.et al. Study on adverse reactions on vaccination. Jpn Med J. 3795:1997;37-41. (in Japanese).
9. Kumagai T., Yamanaka Y., Wataya Y.et al. Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines. J Allergy Clin Immunol. 100:1997;130-134.
10. Boluda L., Fernández-Caldas E., Berrens L. The role of IgG in type-I allergy: an unsolved problem. Invest Allergol Clin Immunol. 7:1997;205-210.
11. Nussenzweig R.S., Merryman C., Benacerraf B. Electrophoretic separation and properties of mouse antihapten antibodies involved in passive cutaneous anaphylaxis and passive hemolysis. J Exp Med. 120:1964;315-328.
12. Daëron M., Couderc J., Ventura M., Liacopoulos P., Voisin G.A. Anaphylactic properties of mouse monoclonal IgG2a antibodies. Cell Immunol. 70:1982;27-40.
13. Schuurman J., Perdok G.J., Mueller G.A., Aalberse R.C. Complementation of Der p 2-induced histamine release from human basophils sensitized with monoclonal IgE: not only by IgE, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2. J Allergy Clin Immunol. 101:1998;404-409.
14. 4 levels as diagnostic and prognostic tests for clinical allergy. J Allergy Clin Immunol. 95:1995;652-654.
15. 4 subclass. Int Arch Allergy Appl Immunol. 53:1977;78-87.
16. 4 induce histamine release from human basophils in vitro. J Allergy Clin Immunol. 70:1982;399-404.
17. 4 molecule. Clin Exp Allergy. 22:1992;1007-1014.